14:52 20/10/2014 4 High-Gross Margin Stocks: Arena Pharmaceuticals, Inc. (ARNA), Gastar ...
4 High-Gross Margin Stocks: Arena Pharmaceuticals, Inc. (ARNA), Gastar ...
Investor Wired (press release) - 8 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has return on equity ratio of -54.10%. The company has $881.56 million in market worth.

14:23 20/10/2014 Hot Biotech Round Up: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Hot Biotech Round Up: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
StreetWise Report - 9 hours ago
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that facts from the stage 3 scientific test program for BELVIQ (lorcaserin HCl) CIV will be launched at the American College of Clinical Pharmacy (ACCP) yearly conference held on last ...
Investor's Alert: Arena Pharmaceuticals, Inc. (ARNA), FuelCell Energy Inc ... - Techsonian (press release)

12:01 20/10/2014 Investor Updates : Auxilium Pharma , Avanir Pharma , Arena Pharma , Novavax ...
Investor Updates : Auxilium Pharma , Avanir Pharma , Arena Pharma , Novavax ...
Markets Insider - 11 hours ago
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) : On October 2, Meeting held at Boston hosted by Jefferies. Auxilium (AUXL) downgraded to Sector Perform from Outperform at RBC Capital.

18:15 17/10/2014 Belviq Sales Dip: What To Watch For Ahead
Belviq Sales Dip: What To Watch For Ahead
Seeking Alpha (registration) - Oct 17, 2014
Sales of the Arena Pharmaceuticals (NASDAQ:ARNA) anti-obesity pill Belviq seem to be seeing some impacts of seasonality with ups and downs as the Fall weeks progress.

14:30 17/10/2014 Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
PR Newswire (press release) - Oct 17, 2014
Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), XOMA Corporation (NASDAQ: XOMA), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), and ...
News Review: Merrimack Pharmaceuticals Inc(NASDAQ:MACK), NPS ... - Market News Call

14:47 15/10/2014 Pfizer Setback Could Help Arena
Pfizer Setback Could Help Arena
Seeking Alpha (registration) - Oct 15, 2014
Yesterday, big pharma giant Pfizer (NYSE:PFE) received news from the FDA that a panel has taken the stance of recommending that a "black box" warning remain attached to the smoking cessation drug Chantix.

15:26 13/10/2014 Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Street Newswire (registration) - Oct 13, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Monday said data from phase 3 clinical trials of its obesity drug BELVIQ (lorcaserin HCl) will be presented at the American College of Clinical Pharmacy meeting taking place through Wednesday of this week.

13:00 13/10/2014 Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl ...
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl ...
PR Newswire (press release) - Oct 13, 2014
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 13, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that data from the Phase 3 clinical trial program for BELVIQ® (lorcaserin HCl) CIV will be presented at the ...

11:52 19/09/2014 Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5%
Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5%
Zacks.com - Sep 19, 2014
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) was a big mover last session, as the company saw its shares rise by nearly 10% on the day.

15:51 17/09/2014 5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
Motley Fool - Sep 17, 2014
Arena Pharmaceuticals (NASDAQ: ARNA ) held a press conference in conjunction with its second-quarter earnings to let investors know what's happening with its obesity drug Belviq and the rest of its pipeline.